NP / PA
Kuldip S. Deogun, MD, PC
Kuldip S. Deogun, MD, PC was paid $208K by Medicaid between Jan 2018 and Nov 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 61% of everything it billed.
33Billing provider infoKULDIP S. DEOGUN, MD, PC
STERLING HEIGHTS, MI 48313
STERLING HEIGHTS, MI 48313
33aNPI1548207467assigned 05/31/2006
33bProvider typeNurse Practitioner
28Total paid$208K
24GClaims4,284
24DCodes billed12
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Nurse Practitioner providers in Michigan
Rank by total paid#18 of 56
Median peer was paid$64K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 679 | $16K | |
| 2019 | 706 | $35K | |
| 2020 | 659 | $30K | |
| 2021 | 583 | $38K | |
| 2022 | 549 | $35K | |
| 2023 | 629 | $29K | |
| 2024incomplete | 479 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 61% | 3,139 | 2,980 | $128K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 33% | 595 | 568 | $68K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.2% | 149 | 142 | $11K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 114 | 105 | $554.78 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 43 | 42 | $481.77 |
| 99152 | <1% | 25 | 25 | $381.27 | |
| 80305 | <1% | 62 | 59 | $276.02 | |
| 99442 | <1% | 16 | 13 | $169.95 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 40 | 38 | $20.35 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | 13 | $10.77 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 31 | 30 | $3.04 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 57 | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEOGUN, KULDIP (PRESIDENT)